Skip to Main Content

A Phase II Risk Adapted Parallel Randomized Trial of MRI-Guided Lattice Stereotactic Focal Radiotherapy of the Prostate with or without Ultra-Short Term Androgen Deprivation Therapy The Miami UAdapt Trial

Principal Investigator

Benjamin Spieler

Enrollment Status

Open

Clinical Trial ID

Institutional Protocol # 20230097

Clinical Trial Summary


Phase

Phase II


Funding Agency/Sponsor

Institutional


Disease

Prostate, Bladder, and Kidney Cancers



Contact Information

Phone Number 305-243-2647